Endo Gets OK To Join FTC's Impax Pay-For-Delay Case
The Federal Trade Commission on Friday gave Endo Pharmaceuticals Inc. the go-ahead to weigh in on the government's administrative proceeding against Impax Laboratories alleging a 2010 settlement between the companies allowing...To view the full article, register now.
Already a subscriber? Click here to view full article